BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30306748)

  • 1. Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy.
    Mitthamsiri W; Pradubpongsa P; Sangasapaviliya A; Boonpiyathad T
    Allergy Asthma Immunol Res; 2018 Nov; 10(6):662-674. PubMed ID: 30306748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of type 2 innate lymphoid cells in pediatric patients with allergic rhinitis.
    Sun R; Yang Y; Huo Q; Gu Z; Wei P; Tang X
    Exp Ther Med; 2020 Jan; 19(1):735-740. PubMed ID: 31853326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic Rhinitis.
    Fan D; Wang X; Wang M; Wang Y; Zhang L; Li Y; Fan E; Cao F; Van Crombruggen K; Zhang L
    Allergy Asthma Immunol Res; 2016 May; 8(3):216-22. PubMed ID: 26922931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen immunotherapy combined with Notch pathway inhibitors improves HDM-induced allergic airway inflammation and inhibits ILC2 activation.
    Tong Y; Wang L; Wang L; Song J; Fan J; Lai C; Bao J; Weng C; Wang Y; Shuai J; Zhang H; Zhang W
    Front Immunol; 2023; 14():1264071. PubMed ID: 38371944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis.
    Fan DC; Wang XD; Wang CS; Wang Y; Cao FF; Zhang L
    Chin Med J (Engl); 2016 Dec; 129(23):2824-2828. PubMed ID: 27900996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D
    Tojima I; Matsumoto K; Kikuoka H; Hara S; Yamamoto S; Shimizu S; Kouzaki H; Shimizu T
    Allergy; 2019 Dec; 74(12):2417-2426. PubMed ID: 31267527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients.
    Qi S; Chen H; Huang N; Li W; Liu G; Wang Y; Hu L; Wang X; Zhang W; Zhu R
    Int Arch Allergy Immunol; 2016; 171(3-4):234-240. PubMed ID: 28049194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis.
    Zhong H; Fan XL; Yu QN; Qin ZL; Chen D; Xu R; Chen DH; Lin ZB; Wen W; Fu QL
    Clin Immunol; 2017 Oct; 183():293-299. PubMed ID: 28917723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.
    Feng M; Zeng X; Li J
    J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
    Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA
    Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy.
    Boonpiyathad T; van de Veen W; Wirz O; Sokolowska M; Rückert B; Tan G; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Ruxrungtham K; Akdis CA; Akdis M
    J Allergy Clin Immunol; 2019 Mar; 143(3):1077-1086.e10. PubMed ID: 30529452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy.
    Eljaszewicz A; Ruchti F; Radzikowska U; Globinska A; Boonpiyathad T; Gschwend A; Morita H; Helbling A; Arasi S; Kahlert H; Berek N; Nandy A; Akdis M; Willers C; Moniuszko M; Akdis CA; Sokolowska M
    J Allergy Clin Immunol; 2021 May; 147(5):1865-1877. PubMed ID: 33039478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients.
    Huang Y; Wang C; Lin X; Lou H; Cao F; Li W; Zhang Y; Zhang L
    Clin Transl Allergy; 2019; 9():64. PubMed ID: 31890153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update.
    Wang C; Bao Y; Chen J; Chen X; Cheng L; Guo YS; Hao C; Lai H; Li H; Li J; Liu C; Liu Y; Liu Z; Lou H; Lv W; Nong G; Qiu Q; Ren X; Shao J; Shen YH; Shi L; Song XC; Song Y; Tang S; Wang H; Wang X; Wang X; Wang Z; Wei Q; Xie H; Xing Z; Xu R; Xu Y; Yang Q; Yao H; Ye J; You Y; Yu H; Yu Y; Zhang H; Zhang G; Zhang Y; Zhi Y; Zhou W; Zhu L; Zhu X; Chai R; Chen D; Guan K; Huang Z; Huang Y; Ma T; Ma Y; Meng Y; Ren L; Wang J; Wang N; Xian M; Xiang R; Zheng M; Zhang L;
    Allergy Asthma Immunol Res; 2022 Nov; 14(6):604-652. PubMed ID: 36426395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy.
    Ihara F; Sakurai D; Yonekura S; Iinuma T; Yagi R; Sakurai T; Ito T; Matsuura A; Morimoto Y; Arai T; Suzuki S; Katayama K; Nakayama T; Okamoto Y
    Allergy; 2018 Sep; 73(9):1823-1832. PubMed ID: 29517806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
    Boonpiyathad T; Lao-Araya M; Chiewchalermsri C; Sangkanjanavanich S; Morita H
    Front Allergy; 2021; 2():747323. PubMed ID: 35387059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis.
    Yao Y; Wang ZC; Wang N; Zhou PC; Chen CL; Song J; Pan L; Liao B; Zhang XH; Yang YS; Xu XY; Zhu RF; Yu D; Liu Z
    J Allergy Clin Immunol; 2019 Jul; 144(1):118-128. PubMed ID: 30796979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.